These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.
Tacrolimus, granules, oral suspension, 0.1 mg
Tacrolimus, parenteral, 5 mg
Everolimus, oral, 0.25 mg
Mycophenolate mofetil, for suspension, oral, 100 mg
Immunosuppressive drug, not otherwise classified
Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
Continued
Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Continued
Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Mannitol, administered through an inhaler, 5 mg
Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams